Marimed (MRMD) Land & Improvements (2015 - 2016)

Marimed (MRMD) posted quarterly Land & Improvements of $686802.0 for Q3 2016, up 283.27% quarter-over-quarter from $179196.0 in Q2 2016.

Marimed (MRMD) Land & Improvements (2015 - 2016) Analysis & Trends

Marimed (MRMD) has reported Land & Improvements for 2 consecutive years, with $686802.0 the latest figure, recorded in Q3 2016.

In Q3 2016, Land & Improvements changed N/A year-over-year to $686802.0; the TTM figure through Sep 2016 stood at $686802.0 (changed N/A YoY), while the FY2015 annual figure was $71488.0, changed N/A from the prior year.
Land & Improvements improved to $686802.0 in Q3 2016 per MRMD's latest filing, from $179196.0 in the prior quarter.
Across five years, Land & Improvements topped out at $686802.0 in Q3 2016 and bottomed at $71488.0 in Q4 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Land & Improvements (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-	-
2	Teva Pharmaceutical Industries	42.98 Bn	39.32 Bn	2.15 Bn	-
3	Zoetis	31.53 Bn	29.86 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.61 Bn	22.81 Bn	5.10 Bn	-
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn	-
6	Viatris	18.74 Bn	17.85 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.51 Bn	15.12 Bn	935.80 Mn	-
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.12 Bn	9.95 Bn	-	-
10	Marimed	27.77 Mn	19.33 Mn	16.23 Mn	-

Download Data